Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Recordati SpA's Enterprise Value is $13,208 Mil.
Recordati SpA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $620 Mil. Therefore, Recordati SpA's EV-to-EBIT ratio for today is 21.32.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Recordati SpA's Enterprise Value is $13,208 Mil.
Recordati SpA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $780 Mil. Therefore, Recordati SpA's EV-to-EBITDA ratio for today is 16.93.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Recordati SpA's Enterprise Value is $13,208 Mil.
Recordati SpA's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2,315 Mil. Therefore, Recordati SpA's EV-to-Revenue ratio for today is 5.71.
Recordati SpA Enterprise Value Historical Data
The historical data trend for Recordati SpA's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Recordati SpA's Enterprise Value
For the Drug Manufacturers - General subindustry, Recordati SpA's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Recordati SpA's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Recordati SpA's Enterprise Value falls into.
Recordati SpA Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Recordati SpA's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Recordati SpA (OTCPK:RCDTF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Recordati SpA's current Enterprise Value is $13,208 Mil.
Recordati SpA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $620 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Recordati SpA's current Enterprise Value is $13,208 Mil.
Recordati SpA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $780 Mil.
Recordati SpA's current Enterprise Value is $13,208 Mil.
Recordati SpA's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,315 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Recordati SpA Enterprise Value Related Terms
Thank you for viewing the detailed overview of Recordati SpA's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Recordati SpA (Recordati SpA) Business Description
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RCDTF has been successfully added to your 